financetom
Business
financetom
/
Business
/
Tyler Technologies beats quarterly revenue estimates on steady cloud demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tyler Technologies beats quarterly revenue estimates on steady cloud demand
Jul 30, 2025 3:13 PM

July 30 (Reuters) - Tyler Technologies ( TYL ) beat Wall

Street expectations for second-quarter revenue on Wednesday,

helped by steady demand for its IT and cloud-based software

services.

Shares of the company rose about 3% in extended trading.

Demand for Tyler's services has grown as more businesses and

government agencies transition to cloud-based solutions to

streamline operations.

The company provides integrated information management

solutions and professional IT services primarily to the public

sector, including local governments, courts, and schools.

It reported second-quarter revenue of $596.1 million,

beating analysts' estimates of $587.9 million, according to data

compiled by LSEG.

The company also slightly raised its annual revenue forecast

to between $2.33 billion and $2.36 billion, up from a prior

range of $2.31 billion to $2.35 billion.

For the quarter ended June 30, Tyler reported earnings

of $1.93 per share, compared with $1.57 per share a year

earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microbix Client Labquality Launching External Quality Assessment Scheme For Head and Neck Cancers
Microbix Client Labquality Launching External Quality Assessment Scheme For Head and Neck Cancers
Sep 17, 2025
07:50 AM EDT, 09/17/2025 (MT Newswires) -- Life sciences company Microbix Biosystems ( MBXBF ) and Finnish company Labquality on Wednesday announced an external quality assessment (EQA) program to help clinical laboratories accurately identify head and neck cancers (HNC) associated with cancer-causing strains of the human papilloma virus (HPV). A pilot EQA study was conducted earlier this year involving 32...
Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint
Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint
Sep 17, 2025
07:48 AM EDT, 09/17/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday its phase 3 study of garetosmab in adults with fibrodysplasia ossificans progressiva, or FOP, met its primary endpoint, demonstrating a greater reduction in new bone lesions compared with placebo. The company said the trial enrolled 63 people with FOP aged at least 18 years old. The...
Form 8.3 - Spirent Communications PLC
Form 8.3 - Spirent Communications PLC
Sep 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Canopy Growth Appoints Tom Stewart as Finance Chief
Canopy Growth Appoints Tom Stewart as Finance Chief
Sep 17, 2025
07:48 AM EDT, 09/17/2025 (MT Newswires) -- Canopy Growth Corporation ( CGC ) said Wednesday that Tom Stewart has been appointed chief financial officer, effective immediately. He has worked as interim CFO since July and has been part of Canopy Growth's ( CGC ) senior finance team since 2019, contributing to initiatives like debt repayments and capital raising, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved